The European Medicines Agency recommended restricting the use of modafinil for narcolepsy only.

The European Medicines Agency has recommended restricting the use of modafinil-containing medicines. The medicine should only be used to treat sleepiness associated with narcolepsy. Doctors and patients should no longer use the medicine for the treatment of idiopathic hypersomnia, excessive sleepiness associated with obstructive sleep apnoea and chronic shift work sleep disorder.”

Click here to download the full press release.

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos